Four Leading Companies Join Int. Serious Adverse Events Consortium to Help Further Global Research Collaboration
Thursday, May 15, 2008 - 08:35
in Mathematics & Economics
The International Serious Adverse Events Consortium (SAEC) announced today that four new members have joined this novel research Consortium, which is working to identify genetic markers that may help predict which individuals are at risk for a range of serious drug-related adverse events (SAEs). These new members include pharmaceutical companies Takeda, Novartis and Daiichi Sankyo and the world's largest medical research charity, The Wellcome Trust.